Kefir, a probiotic-rich fermented milk, shows potential in reducing neuroinflammation, oxidative stress, and beta-amyloid ...

If you’d like to remember the days before X, Engadget points out that an auction for one of two large signs from the company’s pre-acquisition San Francisco headquarters is close to ending. RR Auction ...

Expanding on the success of the MLB Debut Patch, Topps, Major League Baseball and Nike have partnered to recognize baseball's ...

Six of baseball’s top players are adding a little extra shine this season. In collaboration with Topps, Fanatics and Nike, ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

The British pharma company GSK has paused diversity activities for UK workers, claiming that it is obliged to do so in response to executive orders by the US president, Donald Trump. The FTSE 100 ...

The stock of GlaxoSmithKline Pharmaceuticals (GSK Pharma) hit a three-month high of ₹2,640 a share as it surged 5 per cent on Monday before closing at ₹2,638. During the past seven trading days, the ...

The vaccine, GSK’s Arepanrix H5N1 A/American wigeon clade 2.3.4.4b, is based on existing seasonal flu vaccine technology. It was approved in Canada on 19 February, the day the order was placed. In ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other pharmaceutical stocks. Almost no other industry goes as far as the phrase "defensive" as the ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. UK drugmaker GSK is struggling to convince the market that it can deliver on its plans to refill its ...

The PMCPA has turned party pooper, coming down on GSK after learning that a U.K. employee celebrated a post about a prescription drug on LinkedIn. A panel of leaders at the PMCPA, pharma’s ...

GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine sales falling, some market participants say it may draw in activist ...